These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31964151)

  • 1. Elevated Plasma von Willebrand Factor Antigen and Activity Levels Are Associated With the Severity of Coronary Stenosis.
    Yan B; Wang Q; Du W; Zhai S; Gou C; Hu T; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2020; 26():1076029619900552. PubMed ID: 31964151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease.
    Jakob A; Schachinger E; Klau S; Lehner A; Ulrich S; Stiller B; Zieger B
    Eur J Pediatr; 2020 Mar; 179(3):377-384. PubMed ID: 31760507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
    Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
    Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction.
    Yan B; Xu M; Zhao Y; Guo H; Xia L; Ruan C; Zhao Y
    Eur J Haematol; 2017 Sep; 99(3):207-215. PubMed ID: 28523822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Aortic Valve Stenosis.
    Frank RD; Lanzmich R; Haager PK; Budde U
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease.
    Favaloro EJ
    Thromb Haemost; 2010 Nov; 104(5):1009-21. PubMed ID: 20806123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of von Willebrand factor to assess the occurrence and prognosis of acute myocardial infarction.
    Wu N; Chen Y; Hou M
    Ann Palliat Med; 2021 Oct; 10(10):10444-10449. PubMed ID: 34763490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke.
    Dai K; Gao W; Ruan C
    Thromb Res; 2001 Dec; 104(6):389-95. PubMed ID: 11755948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of plasma von Willebrond factor and soluble E-selectin levels in patients with coronary artery disease].
    Lin GQ; Jiang HH; Li YQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):399-402. PubMed ID: 16190382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
    Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
    Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study.
    Kovacevic KD; Mayer FJ; Jilma B; Buchtele N; Obermayer G; Binder CJ; Blann AD; Minar E; Schillinger M; Hoke M
    Atherosclerosis; 2019 Nov; 290():31-36. PubMed ID: 31557676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction.
    Xier Z; Zhu YX; Tang SW; Kong C; Aili D; Huojia G; Peng H
    Front Cardiovasc Med; 2022; 9():1013815. PubMed ID: 36684571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
    Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.